Streetbeat News

Products Services

SPY

USO

During the ABC News Presidential Debate, Vice President Harris stated she will not ban fracking and emphasized the need to invest in diverse energy sources to reduce reliance on foreign oil.

Portfolio Pulse from Benzinga Newsdesk

September 11, 2024 | 1:41 am

SPY

Vice President Harris announced a plan to offer a $50,000 tax deduction to startup small businesses during the ABC News Presidential Debate. This initiative aims to support small business growth and entrepreneurship.

Portfolio Pulse from Benzinga Newsdesk

September 11, 2024 | 1:06 am

JNJ

Johnson & Johnson reports that dexamethasone significantly reduces infusion-related reactions in patients with EGFR-mutated non-small cell lung cancer treated with intravenous RYBREVANT. The study showed a three-fold reduction in IRRs compared to standard management.

Portfolio Pulse from Benzinga Newsdesk

September 10, 2024 | 9:21 pm

DRS

Leonardo DRS has successfully delivered critical C5I capabilities for the Australian Army's heavy armored capability systems ahead of schedule. This delivery highlights the company's efficiency and reliability in providing advanced defense solutions.

Portfolio Pulse from Benzinga Newsdesk

September 10, 2024 | 9:03 pm

BBIO

BridgeBio has decided to halt the development of BBP-631 for congenital adrenal hyperplasia (CAH) and is seeking partnerships to support future development of this or next-generation gene therapies. CAH remains a prevalent genetic disease with significant unmet needs.

Portfolio Pulse from Benzinga Newsdesk

September 10, 2024 | 8:51 pm

BBIO

BridgeBio announced results from its Phase 1/2 trial of the investigational gene therapy BBP-631 for Congenital Adrenal Hyperplasia. The trial showed increased cortisol production in higher dose cohorts, with mild to moderate adverse events. However, the results did not justify further capital investment, leading to a $50M budget reduction for gene therapy.

Portfolio Pulse from Benzinga Newsdesk

September 10, 2024 | 8:49 pm

FTCI

FTC Solar, Inc. (NASDAQ:FTCI) shares surged in after-hours trading following a multi-year agreement with Strata Clean Energy to supply 500 megawatts of solar tracker technology, potentially expanding to over a gigawatt. The first project is expected to start in Q4 2024.

Portfolio Pulse from Erica Kollmann

September 10, 2024 | 8:48 pm

BBIO

BridgeBio Pharma announced that the FDA has granted Regenerative Medicine Advanced Therapy (RMAT) designation to its investigational gene therapy, BBP-812, for Canavan disease. This designation follows positive clinical data from the CANaspire Phase 1/2 trial.

Portfolio Pulse from Benzinga Newsdesk

September 10, 2024 | 8:46 pm

GE

Deep-pocketed investors are showing significant interest in GE Aero options, with a mix of bullish and bearish sentiments. The options activity suggests a focus on a price range of $160 to $185. GE Aero's stock is currently trading at $166.98, with an anticipated earnings release in 42 days.

Portfolio Pulse from Benzinga Insights

September 10, 2024 | 8:46 pm

ENGN

enGene is on track to report preliminary data for its LEGEND study in September 2024. The company has $257.7 million in cash and equivalents, providing financial runway until 2027.

Portfolio Pulse from Benzinga Newsdesk

September 10, 2024 | 8:36 pm